A Randomized, Double-blind, Parallel, Placebo-controlled Study for the Assessment of the Safety and Efficacy of UISH001 for the Symptomatic Improvement of Urinary Incontinence.
Phase of Trial: Phase I/II
Latest Information Update: 18 Jun 2014
At a glance
- Drugs UISH 001 (Primary)
- Indications Urinary incontinence
- Focus Therapeutic Use
- Sponsors Beech Tree Labs
- 07 Nov 2012 Primary endpoint 'Urinary-leaks' has been met, according to a Beech Tree Labs media release.
- 25 May 2012 Actual end date (May 2012) added as reported by ClinicalTrials.gov.
- 25 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.